QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 morgan-stanley-says-elevance-healths-growth-attributed-to-consistent-performance-but-undervalued

Morgan Stanley initiates coverage on Elevance Health with an Overweight rating and a $643 price target. Elevance Health's d...

 morgan-stanley-initiates-coverage-on-elevance-health-with-overweight-rating-announces-price-target-of-643

Morgan Stanley analyst Erin Wright initiates coverage on Elevance Health (NYSE:ELV) with a Overweight rating and announces P...

 elevance-health-exec-says-medicare-earnings-are-growing-this-year-company-is-making-money-to-be-clear-it-is-not-losing-money-in-medicare

- Goldman Sachs Conf

 elevance-health-exec-medicaid-redeterminations-had-impact-on-mix-of-healthy-and-sick-membership

- Goldman Sachs Conf

 cantor-fitzgerald-reiterates-overweight-on-elevance-health-maintains-600-price-target

Cantor Fitzgerald analyst Sarah James reiterates Elevance Health (NYSE:ELV) with a Overweight and maintains $600 price target.

 stephens--co-reiterates-overweight-on-elevance-health-maintains-615-price-target

Stephens & Co. analyst Scott Fidel reiterates Elevance Health (NYSE:ELV) with a Overweight and maintains $615 price target.

 b-of-a-securities-maintains-buy-on-elevance-health-raises-price-target-to-646

B of A Securities analyst Kevin Fischbeck maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $...

 elevance-health-shares-moving-higher-co-now-presenting-at-bernsteins-40th-annual-strategic-decisions-conference-at-900-am-et

Elevance Health (NYSE:ELV) announced today that senior management is scheduled to present at Bernstein's 40th Annual Strate...

 jp-morgan-maintains-overweight-on-elevance-health-raises-price-target-to-631

JP Morgan analyst Lisa Gill maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $628 to ...

 baird-initiates-coverage-on-elevance-health-with-outperform-rating-announces-price-target-of-649

Baird analyst Michael Ha initiates coverage on Elevance Health (NYSE:ELV) with a Outperform rating and announces Price Targe...

 why-unitedhealth-stock-is-sliding-wednesday

UnitedHealth Group Inc. (NYSE: UNH) saw its shares decline significantly following remarks made by CEO Andrew Witty at the Bern...